AZN
The table below shows AstraZeneca PLC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | - | - | - | - | - |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| - |
| - |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | $21.22B | $21.06B | $19.96B | $19.82B | $11.80B | $11.64B |
| Total assets | $112.42B | $104.34B | $96.54B | $96.58B | $73.64B | $59.93B |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | - | - | - | - | - | - |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $67.61B | $64.74B | $59.13B | $60.63B | $57.95B | $46.27B |
| Retained earnings | - | - | - | - | - | - |
| Total equity | - | - | - | - | - | - |